Climb Bio, Inc. (CLYM) Operating cash flow 2020–2025
Climb Bio, Inc. (CLYM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.4MFY2025 · since FY2020: -$14.1M → -$54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.4M | -249.3% |
| FY2024 | -$15.6M | +24.5% |
| FY2023 | -$20.6M | +44.9% |
| FY2022 | -$37.4M | -3.6% |
| FY2021 | -$36.1M | -155.9% |
| FY2020 | -$14.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice